HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
101.48
+0.34 (0.34%)
At close: May 28, 2025, 4:00 PM
101.48
0.00 (0.00%)
After-hours: May 28, 2025, 4:15 PM EDT
HealthEquity Stock Forecast
Stock Price Forecast
According to 13 professional analysts, the 12-month price target for HealthEquity stock ranges from a low of $94 to a high of $130. The average analyst price target of $111.77 forecasts a 10.14% increase in the stock price over the next year.
Price Target: $111.77 (+10.14%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HealthEquity stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 9 | 9 | 9 | 8 | 7 | 8 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 12 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Initiates $112 | Buy | Initiates | $112 | +10.37% | May 22, 2025 |
| Keybanc | Keybanc | Buy Maintains $110 → $100 | Buy | Maintains | $110 → $100 | -1.46% | Apr 16, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $112 | Buy | Maintains | $112 | +10.37% | Apr 11, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $107 → $94 | Hold | Maintains | $107 → $94 | -7.37% | Mar 27, 2025 |
| Raymond James | Raymond James | Buy → Strong Buy Upgrades $120 → $115 | Buy → Strong Buy | Upgrades | $120 → $115 | +13.32% | Mar 25, 2025 |
Financial Forecast
Revenue This Year
1.32B
from 1.20B
Increased by 9.60%
Revenue Next Year
1.45B
from 1.32B
Increased by 10.04%
EPS This Year
3.67
from 1.09
Increased by 236.54%
EPS Next Year
4.48
from 3.67
Increased by 22.00%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.4B | 1.6B | 1.8B |
| Avg | 1.3B | 1.4B | 1.6B |
| Low | 1.3B | 1.4B | 1.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 14.9% | 20.9% | 21.1% |
| Avg | 9.6% | 10.0% | 11.2% |
| Low | 5.8% | 3.3% | 1.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.89 | 4.87 | 5.99 |
| Avg | 3.67 | 4.48 | 5.38 |
| Low | 3.48 | 4.17 | 4.82 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 256.4% | 32.8% | 33.7% |
| Avg | 236.5% | 22.0% | 20.2% |
| Low | 219.2% | 13.8% | 7.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.